2-amino-5-phosphonovalerate has been researched along with Abnormalities, Congenital, Nervous System in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sancini, G | 1 |
| Franceschetti, S | 1 |
| Lavazza, T | 1 |
| Panzica, F | 1 |
| Cipelletti, B | 1 |
| Frassoni, C | 1 |
| Spreafico, R | 1 |
| Acampora, D | 1 |
| Avanzini, G | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Abnormalities, Congenital, Nervous System
| Article | Year |
|---|---|
Potentially epileptogenic dysfunction of cortical NMDA- and GABA-mediated neurotransmission in Otx1-/- mice.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Cell | 2001 |